tiprankstipranks
Trending News
More News >
Alnylam Pharmaceuticals (GB:0HD2)
LSE:0HD2
Advertisement

Alnylam Pharma (0HD2) Similar Shares

Compare
3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Alnylam Pharma
$447.68
$58.53B
70.53%
23 Buy
5 Hold
0 Sell
Strong Buy
Incyte
$84.61
$16.52B
19.23
28.86%
10 Buy
8 Hold
1 Sell
Moderate Buy
Vertex Pharmaceuticals
$391.02
$100.25B
27.95
-21.15%
15 Buy
10 Hold
0 Sell
Moderate Buy
Argenx Se
$712.20
$43.23B
33.46
37.67%
22 Buy
1 Hold
0 Sell
Strong Buy
Genmab
$24.87
$15.29B
12.32
-10.54%
4 Buy
2 Hold
0 Sell
Moderate Buy
BioNTech SE
$100.00
$24.04B
13.35%
14 Buy
5 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GB:0HD2
Alnylam Pharma
447.68
185.16
70.53%
INCY
Incyte
84.61
18.30
27.60%
VRTX
Vertex Pharmaceuticals
391.02
-84.68
-17.80%
ARGX
Argenx Se
712.20
197.97
38.50%
GMAB
Genmab
24.87
-2.54
-9.27%
BNTX
BioNTech SE
100.00
12.00
13.64%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis